Scientists have made a major breakthrough in understanding how the parasite that causes malaria is able to multiply at such an alarming rate, which could be a vital clue in discovering how it has evolved, and how it can be stopped.
An experimental Zika vaccine lowered levels of virus in pregnant monkeys and improved fetal outcomes in a rhesus macaque model of congenital Zika virus infection, according to a new study in Science Translational Medicine.
An innovative graphene-based film helps shield people from disease-carrying mosquitos, according to a new study funded by the National
One element all mosquitoes have in common is their complex sense of smell. Mosquitoes must seek out blood meals (a mosquito “bite” to humans) to reproduce and water sources to lay eggs; however, they have poor vision and instead use scent to find their next meal.
The National Institute of Allergy and Infectious Diseases (NIAID)-funded researchers who developed a genetically modified mosquito-killing fungus, a weapon made from spider toxin, that destroys blood-sucking enemies from the inside and helps save people from disease and death.
Mosquitoes that landed on surfaces coated with the antimalarial compound atovaquone were completely blocked from developing Plasmodium falciparum (P. falciparum), the parasite that causes malaria, according to new research led by Harvard T.H. Chan School of Public Health.
Sierra Leone has achieved vast declines in malaria deaths between 2010 and 2015, the highest in Western Africa. This is linked to a range of interventions, including increased availability of diagnostic tests, free treatments and mass distribution of insecticide treated nets (ITNs).